Biosergen AB BIOSGN.ST Stock
0.47 SEK
{{ price }}
10.874705%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
66.78M SEK
LOW - HIGH [24H]
0.39
-
0.47 SEK
VOLUME [24H]
105.26K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.35 SEK
Biosergen AB Price Chart
Biosergen AB BIOSGN.ST Financial and Trading Overview
| Biosergen AB stock price | 0.47 SEK |
| Previous Close | 1.12 SEK |
| Open | 1.11 SEK |
| Bid | 1.09 SEK x N/A |
| Ask | 1.11 SEK x N/A |
| Day's Range | 1.11 - 1.11 SEK |
| 52 Week Range | 0.99 - 7.2 SEK |
| Volume | 14.02K SEK |
| Avg. Volume | 111.26K SEK |
| Market Cap | 47.09M SEK |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIOSGN.ST Valuation Measures
| Enterprise Value | 29.88M SEK |
| Trailing P/E | N/A |
| Forward P/E | 0.50454545 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.779577 |
| Price/Book (mrq) | 2.6618705 |
| Enterprise Value/Revenue | 7.474 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biosergen AB Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -76.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.2 SEK |
| 52 Week Low | 0.99 SEK |
| 50-Day Moving Average | 1.19 SEK |
| 200-Day Moving Average | 1.67 SEK |
BIOSGN.ST Share Statistics
| Avg. Volume (3 month) | 111.26K SEK |
| Avg. Daily Volume (10-Days) | 91.08K SEK |
| Shares Outstanding | 42.43M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1000.45% |
| Gross Margin | 87.49% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -114.037% |
| Return on Equity (ttm) | -245.090% |
Income Statement
| Revenue (ttm) | 4M SEK |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -280000 SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -39918000 SEK |
| Diluted EPS (ttm) | -1.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.79M SEK |
| Total Cash Per Share (mrq) | 0.4 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.293 |
| Book Value Per Share (mrq) | 0.417 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35892000 SEK |
| Levered Free Cash Flow (ttm) | -20690750 SEK |
Profile of Biosergen AB
| Country | Sweden |
| State | N/A |
| City | Solna |
| Address | Fogdevreten 2 |
| ZIP | 171 65 |
| Phone | 46 4 52 08 02 470 |
| Website | https://biosergen.net |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of invasive fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Q&A For Biosergen AB Stock
What is a current BIOSGN.ST stock price?
Biosergen AB BIOSGN.ST stock price today per share is 0.47 SEK.
How to purchase Biosergen AB stock?
You can buy BIOSGN.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biosergen AB?
The stock symbol or ticker of Biosergen AB is BIOSGN.ST.
Which industry does the Biosergen AB company belong to?
The Biosergen AB industry is Biotechnology.
How many shares does Biosergen AB have in circulation?
The max supply of Biosergen AB shares is 142.39M.
What is Biosergen AB Price to Earnings Ratio (PE Ratio)?
Biosergen AB PE Ratio is now.
What was Biosergen AB earnings per share over the trailing 12 months (TTM)?
Biosergen AB EPS is -0.35 SEK over the trailing 12 months.
Which sector does the Biosergen AB company belong to?
The Biosergen AB sector is Healthcare.
Biosergen AB BIOSGN.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}